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Objective. The study aims at assessing personality tendencies and orientations that could be closely correlated with knowledge,
awareness, and interest toward undergoing genetic testing. Methods. A sample of 145 subjects in Italy completed an online
survey, investigating demographic data, health orientation, level of perceived knowledge about genetic risk, genetic screening,
and personal attitudes toward direct to consumer genetic testing (DTCGT). Results. Results showed that respondents considered
genetic assessment to be helpful for disease prevention, but they were concerned that results could affect their life planning with
little clinical utility. Furthermore, a very high percentage of respondents (67%) had never heard about genetic testing directly
available to the public. Data showed that personality tendencies, such as personal health consciousness, health internal control,
health esteem, and confidence, motivation to avoid unhealthiness and motivation for healthiness affected the uptake of genetic
information and the interest in undergoing genetic testing. Conclusions. Public knowledge and attitudes toward genetic risk and
genetic testing among European countries, along with individual personality and psychological tendencies that could affect these
attitudes, remain unexplored.The present study constitutes one of the first attempts to investigate how such personality tendencies
could motivation to undergo genetic testing and engagement in lifestyle changes.
1. Introduction
Preemptive medicine [1] and the recent progress in genomics
bear the promise that the identification of individual traits,
risk factors, and the prediction of latent diseases may allow
the development of personalized interventions (e.g., themost
efficient drug, with the right dose with the right time-using)
and thus decrease the probability of disease development [2].
There are currently genetic tests for over 1,500 diseases, a
number of which are directly available to the public for per-
sonal use; in the early 1980s several private companies started
to offer genetic testing directly to the citizens (DTCGT).
This situation raises concerns on risk communication, health
responsibility between clinicians and patients, and manage-
ment of the gap between genetic susceptibility and lack of
therapeutic options [3–5]. Nevertheless, we cannot neglect
the fact that genetic information is now an integral part of risk
assessment and that it constitutes a resource for individuals
in some cases [6], who may decide to cope with manageable
factors (e.g., smoking, diet, exercise, and alcohol intake), opt
for specific prophylactic treatments or clinical screenings,
and rearrange future plans (e.g., decisions for the offspring)
(WHO).
Healthcare professionals and policy makers in Europe are
struggling to find effective strategies to communicate genetic
risk information and, at the same time, to enhance individual
empowerment and shared decision making in this field [7].
A considerable amount of studies have investigated the
level of knowledge, attitudes, and ability to manage genetic
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information among general practitioners [8–12] and the
interest of people in genetic testing in many European
countries [13–21]. They attempted to provide a global view of
the general public’s predisposition to consider and undergo
genetic testing, but to date no studies have tried to correlate
these trends with specific psychological tendencies associated
with health [22–24]. Previous literature in the US [25],
instead, put emotional reactions to genetic risk information
in the limelight, but as it focuses almost uniquely on anx-
iety and depression, it failed to capture the most complex
psychological, cognitive, and emotional processes which can
act as motivators for health knowledge acquisition and can
become the precursors of patients’ health engagement and
behavioral change [26]. Hence, the aim of this study was
to assess the personality tendencies that could be closely
correlated with knowledge, awareness, and interest in under-
going genetic testing in a sample of the Italian population.
We choose a sample of Italian citizens, prevalently young
adults and adults [27], with higher education, according to
the cultural standards and the education system in Italy, since
previous studies showed that this cohort of people have more
open attitudes towards new health technologies, are more
interested in scientific progress, and are more confident with
the use of Internet services and platforms (which nowadays
are the most powerful source for information) [13, 15, 28–30].
2. Materials and Methods
2.1. Participants and Procedure. A total of 250 subjects with at
least a bachelor degree were invited by e-mail to complete the
survey.They were recruited through authors’ social networks
and students’ institutional mailing-list via the University of
Milan (Italy) from September 2015 to January 2016. A sample
of 145 subjects agreed to complete our survey; 22.1% were
male (32), whereas 77.9% were female (113). The mean age
was 31.41 (SD = 7.586) (minimum = 21 and maximum = 54)
and among them 49% had a bachelor’s degree, whereas 51%
ranged from master degree to Ph.D. and/or specialization (4
years of training after master degree); 16% of the participants
had children.
Each participant could contact the researcher in order to
receive clarifications about the scope and the methodology
of the study. After this primary contact researcher sent
a link with the questionnaire. Data were collected using
Survey Monkey, an open source online survey application
which enables users to develop and publish online surveys
and register responses (www.surveymokey.com). Overall, the
time required for filling in the questionnaire was 20 minutes.
Participation to the study was voluntary and anonymous.The
research protocol was approved by the Institutional Review
Board of the University of Milan.
2.2. Measures. A structured and self-administered ad hoc
questionnaire was completed by the enrolled participants. It
was divided into different sections.
(i) Demographic Variables. The questionnaire included a set
of specific questions designed to depict sociodemographic
characteristics such as gender, age, marital status, number
of offspring, educational level, and current employment.
Furthermore, twoparameters of physical statuswere included
(weight and height for BMI classification).
(ii) Health Orientation Scale (HOS) [31]. It is a self-adminis-
tered questionnaire that assesses several health-related
personality features. It is composed of fifty items divided into
ten subscales: personal health consciousness (the tendency
to be highly aware of one’s physical health); health image
concern (the tendency to be highly aware of the external,
observable impression that one’s physical health makes on
others); health anxiety (the tendency to be anxious about
one’s physical health); health esteem and confidence (the
tendency to feel confident about one’s physical health); moti-
vation to avoid unhealthiness (the desire to avoid being in a
state of unhealthiness); motivation for healthiness (the desire
to keep oneself in excellent physical health); health internal
control (the tendency to believe that one’s physical health
is dependent upon one’s behaviors); health external control
(the tendency to believe that one’s health status is determined
by factors that do not depend upon ones’ actions); health
expectations (the tendency to expect that one’s health will
be excellent and positive in the future); health status (the
tendency to regard oneself as currently being in good physical
shape).These personality features are intended as inner states
which potentially affect thinking, feelings, and behaviors.
Respondents were asked to indicate the extent to which
they identify with each statement on a 5-point Likert scale
(1 = not at all characteristic of me, 2 = slightly characteristic
of me, 3 = somewhat characteristic of me, 4 = moderately
characteristic of me, and 5 = very characteristic of me). Total
scoring for each subscale was 0–20. The internal consistency
was evaluated using Cronbach alpha coefficient: subscales
reported a value included within 0.69–0.92. However, the
Spearman-Brown coefficient was used to control the reliabil-
ity: subscales reported a value includedwithin 0.82−0.96 [31].
(iii) Genetic Knowledge andAttitudes towardDTCGT. In order
to evaluate the level of perceived knowledge about genetic
risk, genetic testing and DTCGT services, and the implica-
tions for future health behaviors and decisions, respondents
were asked a set of questions selected and adapted from
previous studies [15, 32]. In particular, we considered an
European survey conducted on 725 young adults and adults
on awareness and knowledge about DTCGT [15]. Thus
comparisons could be made between European populations
available. Questions assessed the following pivotal points:
(a) The level of perceived knowledge about genetic risk
(“What is your level of knowledge about genetic risk?”
evaluated using a Likert scale: poor, fair, good, and
excellent), genetic testing (“What is your level of
knowledge about genetic testing?” evaluated using
a Likert scale: poor, fair, good, and excellent), and
DTCGT (“Have you ever heard about genetic tests
that are provided directly to consumers via the Inter-
net (DTC)?” evaluated with a dichotomous response
yes or no)
(b) The sources of information (“Where did you gather
information?” open question)
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(c) The motivation for accepting and/or for refusing the
DTCGT (“For which reason would you consider to
undergo a genetic analysis direct to consumer via
the Internet?” evaluated through listed options), with
the possible impact on current and/or future health
behaviors and decisions (items options “I think it
might influence my difficulty in making decisions
concerning my health,” “I think it can influence my
future decisions” (e.g., decisions related to marriage,
pregnancy, offspring etc.)
(d) The intention to undergo the DTCGT (rated on
a scale from 0, not at all motivated, to 10, highly
motivated).
2.3. Statistical Analysis. Adescriptive analysis was conducted
to report demographic, social, and professional character-
istics of the subjects enrolled. A multivariate analysis of
variance (MANOVA) was calculated using the overall level
of perceived knowledge about genetic risk and genetic testing
(poor, fair, good, and excellent) or genomic medicine and
DTCGT (yes, no) as fixed factor and health-related person-
ality tendency (HOS subscales) as dependent variable (2-
tailed, 𝑝 < .05). The Pearson product-moment coefficient
was used to measure the correlation between intention of the
subjects to undergo genetic testing and their health-related
personality tendency (2-tailed, 𝑝 < .05), considering all ten
subscales of HOS. Analyses were performed including all the
subjects with the SPSS package (version 20.0, IBM, USA,
2014).
3. Results
3.1. DemographicData. Considering the parameters on phys-
ical status, our sample had a mean height of 1.69m (SD =
.0815) and ameanweight of 63.92 kg (SD= 16.382). According
to the international classification the sample had a normal
BMI (M = 22.11 SD = 4.246).
No differences in attitudes and perceived knowledge
toward genetic risk, screening, and direct to consumer
genetic testing were found with regard to sex, age (aged 21
to 30, aged 31 to 40, and aged 41 to 54), physical status
(categories according to international BMI classification),
and educational level (bachelor degree, master degree, post
degree specialization).
3.2. Genetic Knowledge and Attitudes toward Genetic Risk,
Genetic Testing, and DTCGT. Participants declared that
they had an adequate level of information about genetic
risk; indeed, only 9% of the subjects stated having poor
information, while 40% and 38.6% declared having a fair
or good level of knowledge (see Figure 1). Regarding the
perceived knowledge of genetic testing, a more consistent
distribution was observed among all answer options (poor
24.1%; fair 28.3%; good 36.7%; excellent 7.6%) (see Figure 2).
Two dichotomous questions evaluating the familiarity with
personalized genomic medicine and the existence of DTCGT
were used. Subjects were equally distributed among the
following: “I know genomic medicine” (51.7%) and “I do





What is your level of knowledge about “genetic risk”?
Figure 1: Genetic risk knowledge.





What is your level of knowledge about “genetic testing”?
Figure 2: Genetic testing knowledge.
not know genomic medicine” (46.7%). Different results were
observed for DTCGT: subjects who never heard about direct
to consumer genetic testing (66.2%) were twice as much as
people who were aware of DTCGT existence (33%).
3.3. Motivations to Undergo and to Reject DTCGT. Among
participants who declared that they knew about DTCGT, the
foremost reasons to get DTCGT were mainly connected with
health-related motivations and expectations.Thus, “knowing
my current health status” (14.4%), “adopting health behav-
iors” (15.2%), and “increasing early detection of the disease”
(21.4%) were the most frequent answers (see Figure 3).
Interestingly, two motivations guided the idea of rejecting
the DTCGT: “the results might cause worry, interfering with
future behaviors” (17.2%) and “the results are unreliable”
(24.2%) (see Figure 4).
3.4. Sources of Information for Genetic Risk and DTCGT. The
chief sources of information for both genetic risk (45.5%)
and DTCGT (41.4%) were the work-education system, while
other different sources of information mentioned were
approximately equally distributed among participants’ judg-
ments. Data indicated that secondary sources of information
for genetic risk were the mass-media (10.3%) and Internet
(9.7%), whereas those for DTCGT were scientific journals
(11%) and Internet (6.2%) (see Figures 5 and 6).
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Knowing my current health status
Adopting health behaviors
Increasing early detection 
of the diseases
Having a better control on
my health status
Planning my future decisions
Increasing my difficulty to take
the decisions related to my health
Satisfying my scientific interest
Satisfying my curiosity
Other
“For which reason would you consider to undergo a
genetic analysis direct to consumer via the Internet?”
Figure 3: Reasons to use DTCGT.
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The results are unreliable
The results might cause worry, interfering with future behaviors
I think that the information is not useful
I do not want undergoing medical test by internet
I do not want to know my risk to develop future diseases
I am worried about the impact on my personal life
“For which reason would you not consider to undergo a 
genetic analysis direct to consumer via the Internet?”
Figure 4: Reasons to reject DTCGT.






Past experience within family
“Where did you gather information about genetic risk?”
Figure 5: Sources on genetic risk.






Past experience within family
“Where did you gather information about genetic testing?”
Figure 6: Sources on DTCGT.
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Table 1: MANOVA between the level of perceived knowledge of genetic risk and the HOS subscales scores.





Genetic risk knowledge Personal health consciousness (PHC) 3 41.854 4.163 .007 .085 11.997 .828
Health internal control (HIC) 3 48.188 3.817 .012 .082 11.566 .812
Table 2: Post hoc Bonferroni test.
Genetic risk knowledge Mean difference (𝐼 − 𝐽) Std. error Sig. Lower bound Upper bound
Personal health consciousness (PHC) Poor Fair −3.06 .996 .015 −5.73 −.39
Good −3.95 1.226 .010 −7.23 −.66
Health internal control (HIC) Poor Fair −3.00 1.103 .044 −5.96 −.05
Good −4.19 1.340 .013 −7.78 −.60
Table 3: MANOVA between the level of perceived knowledge on genetic testing and HOS subscales scores.








Personal health consciousness (PHC) 3 39.051 3.931 .010 .079 11.223 .800
Motivation to avoid unhealthiness (MAU) 3 41.896 3.760 .012 .066 9.196 .707
Motivation for healthiness (MH) 3 62.921 4.303 .006 .083 11.879 .824
Health internal control (HIC) 3 57.439 4.551 .005 .100 14.533 .898
Table 4: Post hoc Bonferroni test.
DTCGT knowledge Mean difference (𝐼 − 𝐽) Std.error Sig.
95% confidence interval
Lower bound Upper bound
Personal health consciousness (PHC) Poor Fair −2.21 .767 .028 −4.26 −.15
Motivation to avoid unhealthiness (MAU) Poor Fair −2.32 .878 .054 −4.68 .03
Motivation for healthiness (MH) Poor Fair −2.87 .946 .017 −5.41 −.34
Health internal control (HIC) Poor Fair −2.81 .817 .005 −5.00 −.62
Good −3.21 1.190 .047 −6.40 −.02
3.5. Health Attitudes That Affect the Knowledge about
Genetic Risk andDTCGT. Amultivariate analysis of variance
(MANOVA) between subjects was used to evaluate whether
specific personality attitudes might affect the tendency to get
information about genetic risk and genetic testing.
The level of perceived knowledge of genetic risk (poor,
fair, good, and excellent) was set as a fixed factor, distinguish-
ing groups of subjects based on the level of perceived genetic
knowledge, and the HOS subscales scores as dependent
variables. Statistically significant differences among groups
were found for two of the HOS subscales: personal health
consciousness (PHC) and health internal control (HIC). Data
showed that subjects who were better informed on genetic
risk had a higher level of PHC (Wilks’s Λ = .015; 𝐹(3) =
4.163 𝑝 = .007) and HIC (Wilks’s Λ = .015; 𝐹(3) = 3.817 𝑝 =
.012) (see Tables 1 and 2).
A separate MANOVA was applied to examine the asso-
ciation between the level of perceived knowledge on genetic
testing (poor, fair, good, and excellent), used as a fixed
factor, and HOS subscales scores as dependent variables.
Statistically significant differences among groups were found
for fourHOS subscales: personal health consciousness (PHC)
(Wilks’s Λ = .013; 𝐹(3) = 3,931 𝑝 = .010); health internal
control (HIC) (Wilks’s Λ = .013; 𝐹(3) = 4.551 𝑝 = .005);
motivation to avoid unhealthiness (MAU) (Wilks’s Λ = .013;
𝐹(3) = 3.760 𝑝 = .012); motivation for healthiness (MH)
(Wilks’s Λ = .013; 𝐹(3) = 4.303 𝑝 = .006) (see Tables 3 and
4). It was observed that higher levels in these subscales were
associated with better reported knowledge on genetic testing.
3.6. Health Attitudes That Affect the Intention to Undergo
to the DTCGT. The Pearson product-moment correlation
coefficient was used to measure the association between
subjects’ health-related personality features and the intention
to undergo DTCGT (0, not at all motivated, to 10, highly
motivated). health esteem and confidence subscales were
negatively correlated to the intention to undergo the DTCGT
(𝑋2 = −.208 𝑝 = .014). Subjects who score high in this
subscale tend to report a high self-confidence toward their
health status.
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4. Discussion
Genomic medicine is a major step forward for the medical
and scientific community. Broadly speaking, public attitudes
towards genetic testing in Europe are positive [17–19, 32–34].
They tend to differ by country and in relation to individual
features such as age, gender, and educational level [33, 35].
For instance, in the UK [13], Greece [15], and Finland
[17, 33], younger people and males reported a higher level
of interest in genetic testing and DTCGT, along with a
more open attitude towards new health technologies [27]. In
the Netherlands [18] a significant difference between lower
and higher-educated people emerged, with lower-educated
respondents showing more interest in genetic testing than
higher-educated respondents. In our population, which rep-
resents a specific age and educational range of the Italian
population (see Participants and Procedure), we verified if
there should be significant differences based on the single
instructional titles and based on three different decades.
Overall, we found no statistical differences of perceived
knowledge toward genetic risk, testing,DTCGT, and attitudes
towards undergoing genetic testing based on sex, age, physi-
cal status, and educational level.
Our results show that, overall, participants claimed to
have a good knowledge about genetic risk and genetic testing,
although more than half of them never heard about DTCGT
(66.2%). This low rate of knowledge about DTCGT was also
observed in studies conducted in the UK [13], where the level
of awareness among the general public was about 13%, and
Greece [15], with only one-third of the population aware of
DTCGT.
Our respondents considered genetic assessment to be
helpful for disease prevention and for gathering information
on their health status and disease detection, but they were
concerned that results could affect their life planning with lit-
tle clinical utility. Our results are in accordance with previous
studies conducted on similar cohorts of subjects in Europe,
which showed that better knowledge about genetics did not
simply lead to unambiguous acceptance of genetic testing and
that a considerable proportion of people in Europe have some
worries and doubts [13, 17, 32, 33, 36, 37]. The most popular
reasons to approve genetic testing in Europe were that it is
useful to adopt a healthier lifestyle and live longer [13, 19, 36],
to learn more about one’s health status, and to find out one’s
disease risk [13, 15, 30]. Instead the most mentioned reasons
for refusal to take up genetic testing, DTCGT in particular,
were that genetic testing should be performed mainly in the
hospital or with a physician’s mediation and/or it should be
directed towards curable or preventable diseases [15, 18, 37]
since it might cause people to become excessively worried or
would impact future plans about offspring [30, 33, 36].
In our sample as well, most of respondents claimed to
have specific concerns about DTCGT, such as “the results
are unreliable” and “the results might cause worry interfering
with future behaviors.” We argue that these results could be
read in light of the fact that in Italy genetic tests are primarily
offered within health care systems, and most respondents
believe that it is how they should continue to be offered, that
is, in regular healthcare contexts (such as the hospital), which
are able to guarantee the needed quality check.
Interestingly, one reason frequently reported in the litera-
ture among the motivations to undergo DTCGT is interest in
the health status of one’s children [38, 39], such as learning
about their children’s risk [40]. Conversely, we found that
none of our participants addressed this issue. This might be
due to the lack of a specific item addressing this issue into
our survey (despite the presence of “other reasons” among
the options), or the lack of knowledge about what kind of
information genetic testing can provide the health status of
one’s offspring, or because they just do not want to know the
genetic condition of their offspring.
Findings from other studies have reported that if the
media pay serious attention to genetics, then people’s expec-
tations of the benefits of genetic testing increase, as does its
use [19]. In our population, about half of the respondents rec-
ognized the work and educational domain as the best infor-
mation source in the area of genetic risk (41% of participants)
and genetic screening and genetic services (45.5%). Thus the
school or academic fields are the primary source for informa-
tion about genetics, while Internet and overallmassmedia are
only a secondary source for genetic information and genetic
services disclosure. This could explain why DTCGT is virtu-
ally unknown among our targeted population, compared to
many other countries: DTCGT is largely advertised on the
private companies’ web sites [41, 42] that are not the favored
genetic information sources for our population.
We investigatedwhich personality attitudes toward health
could influence the uptake of genetic information, genetic
knowledge, and awareness and the interest in undergoing
genetic testing. Interestingly our results showed that people
who aremore informed about genetic risk and genetic testing
have a high personal health consciousness (PHC) and a
health internal control (HIC). Health consciousness is a
multifaceted concept [43–45], and it could be explained as
the tendency to think about one’s physical health and fitness
[31]. PHC is, first of all, a psychological or inner status [45]
which includes health alertness, health involvement, and self-
monitoring [46, 47], different from health anxiety or fear of
being sick or of dying. In our sample people who were more
predisposed to devote attention to their health status (high
PHC) were more interested and predisposed to gather info
about genetic risk, genetic testing, and even DTCGT; these
later prevalently spread by mass media channels (Internet).
Participants with more knowledge about DTCGT had, more-
over, high motivation to avoid unhealthiness (MAU) and
motivation for healthiness (MH). This means that they are
more predisposed to engage with active solutions and health-
related behaviors such as information seeking; they are active
in avoiding behaviors and activities which undermine their
physical health and preserve their wellness [48].
Another important personal component, which proved
to be related to genetic knowledge and interest, was the
Health Locus of Control (HLC). HLC is the extent to which
individuals believe that their health is determined by their
own actions or by environmental circumstances and power-
ful external agents and thus whether it is manageable or not
[49, 50]. An internal locus of control suggests that one’s health
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outcome is under the direct control of one’s own actions.
In general, people who believe that they could influence
their health status with health-related behaviors are more
likely to avoid health risks and adopt preventive solutions. As
outlined before, our results show that participants with high
HIC (health internal control) gather more information about
what actual scientific progress has to offer in the domain
of prevention and personalized treatments, such as genetic
testing including DTCGT.
We asked participants who claimed to have a good
knowledge of DTCGT whether they would be interested in
undergoing DTCGT. Participants who were more interested
in undergoing DTCGT had low levels of health esteem and
confidence, a measure of how much someone is feeling good
about himself/herself, believing in himself/herself andhis/her
wellness. This could mean that the more a person is critical
about his/her physical wellness, the more he/she is interested
in undergoing genetic testing even if there is no medical
prescription, believing that such kind of information could
reassure themabout their health or give therapeutic solutions.
This kind of tendencies could lead to inappropriate and
useless health-related decisions.
5. Conclusions
We can summarize that the population of Italian respondents
has a rather poor knowledge of genetic medicine and of
DTCGT. Also, they seem to mostly rely on work and edu-
cational domain to gain information about such topics. As a
consequence, in the need of increasing the population literacy
and the possibility to make informed decisions on genetic
matters [6], it could be useful to convey such information
in a way that would be perceived as reliable (e.g., through
institutional programs).
However, in order to embed genetic risk information and
genetic testing in health programs, we need to understand
people’s psychological traits, attitudes, beliefs, and decision
making processes [51–53] that could potentially influence the
motivation to search for genomic risk information, decision
to undergo genetic testing, and engaging in lifestyle changes.
The present study is a first attempt to assess person-
ality tendencies and orientations that could be correlated
with knowledge, awareness, and interest toward undergoing
genetic testing. We found that some measurable charac-
teristics, such as high personal consciousness, and health
internal control were correlated to interest and knowledge
on genetic matters and to the preferred way to search for
information. However, this promising research topic needs to
be investigated more deeply.
Finally, we recognize two possible limitations of our
study: the selection of participants did not include elderly
people (in order to guarantee the participation of computer-
literate individuals) and participants were not “real” con-
sumers butwe asked for their hypothetical interest inDTCGT
and genetic testing in general.
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